A CT head shows a possible aneurysm in the P2 segment of the cerebral artery; should an MRI (magnetic resonance imaging) or MRA (magnetic resonance angiography) be performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, obtain MRA head to confirm the possible P2 aneurysm

When CT head shows a possible aneurysm, you should proceed with MRA head as the next diagnostic step to confirm or exclude the aneurysm before considering more invasive imaging. MRA is the ideal noninvasive confirmatory test in this scenario 1.

Why MRA is the Appropriate Next Step

MRA head demonstrates 95% sensitivity and 89% specificity for intracranial aneurysm detection and serves as an ideal candidate for aneurysm evaluation due to its noninvasive nature and ability to obtain diagnostic information without IV contrast 1. The ACR Appropriateness Criteria (2021) specifically identifies MRA as optimal for aneurysm surveillance and evaluation.

Key Advantages of MRA in Your Case:

  • Noninvasive confirmation: When CT suggests but doesn't definitively show an aneurysm, MRA provides high-quality vascular imaging without catheter-based risks
  • No radiation exposure: Unlike CTA, MRA avoids additional radiation
  • Enhanced accuracy with 3T scanners: Diagnostic accuracy increases for aneurysms <5 mm at 3T field strength 1
  • Can be performed without contrast: Time-of-flight MRA provides excellent vascular detail without IV gadolinium, though contrast-enhanced MRA may improve visualization of complex flow dynamics 1

Alternative: CTA Head

CTA head is also appropriate and demonstrates >90% sensitivity and specificity for aneurysm detection 1. Choose CTA if:

  • MRI is contraindicated (pacemaker, certain metallic implants, severe claustrophobia)
  • Faster imaging is needed
  • The patient cannot tolerate prolonged MRI scanning

However, be aware that CTA sensitivity decreases for aneurysms <3 mm and for aneurysms adjacent to bone (which can be relevant for P2 segment location near the skull base) 1.

Important Caveats

False-Positive Risk with MRA:

Research shows that MRA can produce false-positives in 38% of cases, particularly for aneurysms <5 mm 2. Vessel loops and infundibular vessel origins commonly mimic aneurysms on MRA 1. This means if MRA is positive, you may still need catheter angiography for definitive characterization before treatment decisions.

When to Proceed Directly to DSA:

Digital subtraction angiography (DSA) remains the reference standard with highest spatial resolution 1. Consider proceeding directly to DSA if:

  • The patient is a surgical candidate and treatment is likely regardless of confirmation
  • Both noninvasive studies (CT and MRA/CTA) show conflicting results
  • Precise anatomical detail is needed for treatment planning

Clinical Algorithm

  1. Start with MRA head (or CTA if MRI contraindicated)
  2. If MRA confirms aneurysm: Proceed to multidisciplinary evaluation for treatment vs. observation decision
  3. If MRA is negative but clinical suspicion remains high: Consider DSA as definitive test
  4. If MRA shows equivocal findings: Proceed to DSA for definitive characterization

Why This Matters for Morbidity and Mortality:

Unruptured aneurysms carry rupture risk with devastating consequences (subarachnoid hemorrhage has high mortality). However, 4-18% of aneurysms demonstrate growth on follow-up with 12-fold higher rupture risk in growing aneurysms 1. Accurate diagnosis is essential because preventive treatment itself carries procedural risks. The noninvasive confirmation step with MRA balances the need for accurate diagnosis against the small but real risks of invasive catheter angiography (stroke, vessel injury).

Bottom line: Order MRA head to confirm or exclude the possible P2 aneurysm, recognizing you may still need DSA for definitive characterization if treatment is being considered.

Related Questions

What are the clinical signs and symptoms of an aneurysm?
What is the appropriate management for a patient with a 1 mm × 1 mm laterally oriented outpouching in the cavernous segment of the right internal carotid artery (possible aneurysm), a hypoplastic right vertebral artery that supplies most flow to the posterior inferior cerebellar artery (PICA) with a diminutive mid‑to‑distal V4 segment, patent proximal intracranial arteries, and a hypoplastic anterior communicating artery?
Is a patient with an abdominal aortic aneurysm measuring 3.3 × 3.2 × 3.1 cm on CT aortogram considered low‑risk or high‑risk for undergoing esophagogastroduodenoscopy (EGD) and colonoscopy?
In a patient with a sentinel headache, is a concurrent decrease in level of consciousness part of the warning sign, or does it indicate that the aneurysm has already caused bleeding?
Can abdominal aortic aneurysms (AAA) cause leg swelling?
How should I describe vortioxetine (Trintellix) to a patient with depression and anxiety, emphasizing how it differs from selective serotonin reuptake inhibitors (SSRIs) regarding side effects?
What effect does Enbrel (etanercept) have on platelet count?
How does methotrexate affect platelet count?
When is Fiberoptic Endoscopic Evaluation of Swallowing (FEES) indicated and how is it performed in a patient with dysphagia or suspected aspiration?
What is trazodone and how should it be recommended for adult patients without significant liver disease, cardiac conduction abnormalities, or a history of serotonin syndrome?
What are the recommended dosing regimens for commonly used antibiotics in an adult with normal renal and hepatic function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.